跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 35,486 条关于
“RTK-driven tumors”
全部
35,486
临床试验
23,184
药物
1,431
机构
119
资讯
10,752
11个月前
Pinetree Therapeutics Secures $47 Million Series B to Advance Novel Protein Degraders for Drug-Resistant Cancers
去年
Avistone's ANS014004, a Novel c-Met Inhibitor, Advances in Phase I Trials for Solid Tumors
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
3个月前
Pathology-Driven Biomarkers Emerge as Critical Tools for Predicting Immunotherapy Response in Solid Tumors
2年前
IAG933, a Novel YAP/TAZ-TEAD Inhibitor, Shows Promise in Preclinical Cancer Models
2年前
Biomarker-Driven Clinical Trial Designs: Basket, Umbrella, and Platform Trials in Precision Medicine
去年
Quanta Therapeutics' QTX3544 Receives FDA IND Clearance for KRASG12V-Driven Solid Tumors
去年
FORE Biotherapeutics Advances Plixorafenib in BRAF-Driven Tumors, Eyes Potential FDA Submission
2年前
Solid Tumor Market Sees Innovation with Aethlon Medical's Hemopurifier Trial and New Immunotherapy Approvals
去年
Novel Strategies Emerge to Transform 'Cold' Tumors into Immunotherapy-Responsive 'Hot' Tumors
第 1 页,共 1076 页
上一页
下一页